Características clínicas e epidemiológicas da Síndrome de Takotsubo em comparação com a Síndrome Coronariana
##plugins.themes.bootstrap3.article.sidebar##
Publicado
Apr 15, 2023
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: Comparar a Síndrome de Taksotsubo (STT) com a Síndrome Coronariana Aguda (SCA) no que tange a características clínicas, epidemiológicas, além de suas estratégias diagnósticas. Métodos: Este é um estudo de abordagem qualitativa e caráter descritivo, executado por meio de revisão integrativa da literatura. As bases de dados utilizadas foram o National Library of Medicine (PubMed), MEDLINE e LILACS. Aplicados os descritores: “Takotsubo Cardiomyopathy”, “Diagnosis” e “Prevalence”, utilizando o operador “AND” entre as respectivas palavras. Resultados: Foram analisados 492, destes, 30 foram selecionados. Os pacientes apresentavam queixa de dor torácica, alterações no ECG, discreta elevação de biomarcadores e ausência de obstrução coronariana grave. Esta doença possui maior prevalência no sexo feminino após à menopausa. Os críterios de Mayo Clinic são utilizados para o diagnóstico da STT e podem ser úteis na diferenciação com outras doenças. Considerações finais: A STT configura-se como desafio diagnóstico, com reconhecimento dificultado pela sobreposição de sintomas e alterações de exames complementares comuns a outras condições, como a SCA. Porém, características epidemiológicas e escores diagnósticos podem ser determinantes para sua identificação.
##plugins.themes.bootstrap3.article.details##
Como Citar
SaloioR. M., OliveiraM. E. L. de, CamposM. B. R., GilbertoM. P. M., SantiagoF., CavalieriL. P. da S., SantosS. C. M. dos, & AlvarengaV. M. (2023). Características clínicas e epidemiológicas da Síndrome de Takotsubo em comparação com a Síndrome Coronariana. Revista Eletrônica Acervo Científico, 44, e12385. https://doi.org/10.25248/reac.e12385.2023
Seção
Artigos
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
1. ALASHI A, et al. Characteristics and outcomes of patients with takotsubo syndrome: incremental prognostic value of baseline left ventricular systolic function. Associação J AM Heart, 2020; 9(16): e016537.
2. ALMEIDA GLG et al. Registro multicêntrico de takotsubo (Remuta) – aspectos clínicos, desfechos intra- hospitalares e mortalidade a longo prazo. Arquivos Brasileiros de Cardiologia; 2020; 115(2): 207–16.
3. ARCARI L, et al. Incidence, determinants and prognostic relevance of dyspnea at admission in patients with Takotsubo syndrome: results from the international multicenter GEIST registry. Sci Rep, 2020; 10 (1): 13603.
4. BENTO D, et al. Short- and medium-term prognosis of Takotsubo syndrome in a Portuguese population. Revista Portuguesa de Cardiologia, 2019; 38(5): 349–57.
5. CITRO R, et al. Long‐term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction. Eur J Heart Fail, 2019; 21(6): 781–9.
6. DING KJ, et al. Intraventricular thrombus formation and embolism in takotsubo syndrome: insights from the international takotsubo registry. ATVB, 2020; 40(1): 279–87.
7. DOYEN D, et al. Incidence, clinical features and outcome of Takotsubo syndrome in the intensive care unit. Archives of Cardiovascular Diseases, 2020; 113(3): 176–88.
8. El‐BATTRAWY I, et al. Incidence and clinical impact of recurrent takotsubo syndrome: results from the geist registry. Associação J Am Heart, 2019; 8(9): e010753.
9. El-BATTRAWY I, et al. Prevalence of malignant arrhythmia and sudden cardiac death in takotsubo syndrome and its management. EP Europace, 2018; 20(5): 843–50.
10. El-BATTRAWY I, et al. Incidence and Prognostic Relevance of Cardiopulmonary Failure in Takotsubo Cardiomyopathy. Representante Científico, 2017; 7(1): 14673.
11. EITEL I, et al. Optical coherence tomography to evaluate plaque burden and morphology in patients with takotsubo syndrome. Associação J Am Heart, 2016; 5(12): e004474.
12. GLAVECKAITĖ S, et al. Clinical features and three-year outcomes of Takotsubo (Stress) cardiomyopathy: Observational data from one center. Hellenic Journal of Cardiology, 2016; 57(6): 428–34.
13. GILI S e CAMMANN VL, et al. Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry. European Heart Journal, 2019; 40(26): 2142–51.
14. GHADRI J-R, et al. International expert consensus document on takotsubo syndrome (Part i): clinical characteristics, diagnostic criteria, and pathophysiology. European Heart Journal, 2018; 39(22): 2032–46.
15. GHADRI JR et al. Long-term prognosis of patients with takotsubo syndrome. Journal of the American College of Cardiology, 2018; 72(8): 874–82.
16. GIRARDEY M, et al. Impact of malignancies in the early and late time course of takotsubo cardiomyopathy. Circ J., 2016; 80(10): 2192–8.
17. ISOGAI T, et al. Apical Takotsubo syndrome versus anterior acute myocardial infarction: findings from the Tokyo Cardiovascular Care Unit network registry. European Heart Journal: Acute Cardiovascular Care, 2019; 8(1): 86–95.
18. JESEL L, et al. Atrial arrhythmias in Takotsubo cardiomyopathy: incidence, predictive factors, and prognosis. EP Europace, 2019; 21(2): 298–305.
19. KATO K, et al. Recurrence of takotsubo cardiomyopathy. International Cardiovascular Forum Journal, 2016; 05.
20. LEMOR A, et al. Impact of gender on in‐hospital outcomes in patients with Takotsubo syndrome: A nationwide analysis from 2006 to 2014. Clin Cardiol, 2019; 42(1): 13–8.
21. LYON AR, et al. Current state of knowledge on takotsubo syndrome: a position statement from the taskforce on takotsubo syndrome of the heart failure association of the european society of cardiology: current state of knowledge on takotsubo syndrome. Eur J Heart Fail, 2016; 18(1): 8–27.
22. MARON BJ, et al. Contemporary definitions and classification of the cardiomyopathies: an american heart association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation, 2006; 113(14): 1807–16.
23. MEDINA DE CHAZAL H, et al. Stress cardiomyopathy diagnosis and treatment. Journal of the American College of Cardiology, 2018; 72(16): 1955–71.
24. MENEGASSI FGM, et al. Miocardiopatia de Takotsubo: Características e Mecanismos Etiológicos, uma revisão narrativa-crítica. Revista Eletrônica Acervo Saúde, 2019; 22: e380.
25. MOADY G, et al. A comparative retrospective study of patients with takotsubo syndrome and acute coronary syndrome. Isr Med Assoc J, 2021; 23(2): 107–10.
26. OTTEN AM, et al. Diagnosis of takotsubo cardiomyopathy is increasing over time in patients presenting as ST-elevation myocardial infarction. Neth Heart J., 2016; 24(9): 520–9.
27. PARODI G, et al. Risk stratification using the cha 2 ds 2 ‐vasc score in takotsubo syndrome: data from the takotsubo italian network. Associação J Am Heart., 2017; 6(9): e006065.
28. PRASAD A, et al. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): A mimic of acute myocardial infarction. American Heart Journal, 2008; 155(3): 408–17.
29. ROSHANZAMIR S, et al. Takotsubo cardiomyopathy a short review. Curr Cardiol., 2013; 9(3): 191–6.
30. SACHDEV E, et al. Women’s Heart Center, Cedars-Sinai Heart Institute, Los Angeles, California, US. Takotsubo cardiomyopathy. European Cardiology Review, 2015; 10(1): 25.
31. SANTORO F, et al. Assessment of the german and italian stress cardiomyopathy score for risk stratification for in-hospital complications in patients with takotsubo syndrome. JAMA Cardiol., 2019; 4(9): 892.
32. SANTOS CRRE, et al. Síndrome de Takotsubo: fisiopatologia, diagnóstico diferencial e tratamento. Revista Eletrônica Acervo Saúde, 2022; 15(2): e9371.
33. SANTOS MTC, et al. Principais características da síndrome de Takotsubo: uma revisão de literatura. Revista Eletrônica Acervo Saúde, 2022; 15(2): e9652.
34. SOUZA MSR, et al. A infecção por coronavírus e a cardiomiopatia de Takotsubo na era da pandemia do SARS-CoV 2. Revista Eletrônica Acervo Científico, 2021; 25: e7368.
35. STIERMAIER T, et al. Prevalence and prognostic impact of diabetes in takotsubo syndrome: insights from the international, multicenter geist registry. Dia Care, 2018; 41(5): 1084–8.
36. SACHDEV E, et al. Women’s Heart Center, Cedars-Sinai Heart Institute, Los Angeles, California, US. Takotsubo cardiomyopathy. European Cardiology Review, 2015; 10(1): 25.
37. TEMPLIN C, et al. Clinical features and outcomes of takotsubo (Stress) cardiomyopathy. N Engl J Med, 2015; 373(10): 929–38.
38. URIBARRI A, et al. Short‐ and long‐term prognosis of patients with takotsubo syndrome based on different triggers: importance of the physical nature. JAHA, 2019; 8(24).
39. VALLABHAJOSYULA S, et al. Tako‐tsubo cardiomyopathy in severe sepsis: nationwide trends, predictors, and outcomes. J Am Heart Assoc., 2018; 7(18).
40. YAYEHD K, et al. Management of takotsubo cardiomyopathy in non-academic hospitals in france: the observational french syndromes of takotsubo (Ofsett) study. Archives of Cardiovascular Diseases, 2016; 109(1): 4–12.
41. YERASI C, et al. Predictors of 90-day readmission and in-hospital mortality in takotsubo cardiomyopathy: an analysis of 28,079 index admissions. Cardiovascular Revascularization Medicine, 2019; 20(11): 973–9.
42. ZALEWSKA-ADAMIEC M, et al. The grace scale in the prognosis of patients with takotsubo syndrome. Journal of Interventional Cardiology, 2020; 2020: 1–7.
2. ALMEIDA GLG et al. Registro multicêntrico de takotsubo (Remuta) – aspectos clínicos, desfechos intra- hospitalares e mortalidade a longo prazo. Arquivos Brasileiros de Cardiologia; 2020; 115(2): 207–16.
3. ARCARI L, et al. Incidence, determinants and prognostic relevance of dyspnea at admission in patients with Takotsubo syndrome: results from the international multicenter GEIST registry. Sci Rep, 2020; 10 (1): 13603.
4. BENTO D, et al. Short- and medium-term prognosis of Takotsubo syndrome in a Portuguese population. Revista Portuguesa de Cardiologia, 2019; 38(5): 349–57.
5. CITRO R, et al. Long‐term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction. Eur J Heart Fail, 2019; 21(6): 781–9.
6. DING KJ, et al. Intraventricular thrombus formation and embolism in takotsubo syndrome: insights from the international takotsubo registry. ATVB, 2020; 40(1): 279–87.
7. DOYEN D, et al. Incidence, clinical features and outcome of Takotsubo syndrome in the intensive care unit. Archives of Cardiovascular Diseases, 2020; 113(3): 176–88.
8. El‐BATTRAWY I, et al. Incidence and clinical impact of recurrent takotsubo syndrome: results from the geist registry. Associação J Am Heart, 2019; 8(9): e010753.
9. El-BATTRAWY I, et al. Prevalence of malignant arrhythmia and sudden cardiac death in takotsubo syndrome and its management. EP Europace, 2018; 20(5): 843–50.
10. El-BATTRAWY I, et al. Incidence and Prognostic Relevance of Cardiopulmonary Failure in Takotsubo Cardiomyopathy. Representante Científico, 2017; 7(1): 14673.
11. EITEL I, et al. Optical coherence tomography to evaluate plaque burden and morphology in patients with takotsubo syndrome. Associação J Am Heart, 2016; 5(12): e004474.
12. GLAVECKAITĖ S, et al. Clinical features and three-year outcomes of Takotsubo (Stress) cardiomyopathy: Observational data from one center. Hellenic Journal of Cardiology, 2016; 57(6): 428–34.
13. GILI S e CAMMANN VL, et al. Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry. European Heart Journal, 2019; 40(26): 2142–51.
14. GHADRI J-R, et al. International expert consensus document on takotsubo syndrome (Part i): clinical characteristics, diagnostic criteria, and pathophysiology. European Heart Journal, 2018; 39(22): 2032–46.
15. GHADRI JR et al. Long-term prognosis of patients with takotsubo syndrome. Journal of the American College of Cardiology, 2018; 72(8): 874–82.
16. GIRARDEY M, et al. Impact of malignancies in the early and late time course of takotsubo cardiomyopathy. Circ J., 2016; 80(10): 2192–8.
17. ISOGAI T, et al. Apical Takotsubo syndrome versus anterior acute myocardial infarction: findings from the Tokyo Cardiovascular Care Unit network registry. European Heart Journal: Acute Cardiovascular Care, 2019; 8(1): 86–95.
18. JESEL L, et al. Atrial arrhythmias in Takotsubo cardiomyopathy: incidence, predictive factors, and prognosis. EP Europace, 2019; 21(2): 298–305.
19. KATO K, et al. Recurrence of takotsubo cardiomyopathy. International Cardiovascular Forum Journal, 2016; 05.
20. LEMOR A, et al. Impact of gender on in‐hospital outcomes in patients with Takotsubo syndrome: A nationwide analysis from 2006 to 2014. Clin Cardiol, 2019; 42(1): 13–8.
21. LYON AR, et al. Current state of knowledge on takotsubo syndrome: a position statement from the taskforce on takotsubo syndrome of the heart failure association of the european society of cardiology: current state of knowledge on takotsubo syndrome. Eur J Heart Fail, 2016; 18(1): 8–27.
22. MARON BJ, et al. Contemporary definitions and classification of the cardiomyopathies: an american heart association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation, 2006; 113(14): 1807–16.
23. MEDINA DE CHAZAL H, et al. Stress cardiomyopathy diagnosis and treatment. Journal of the American College of Cardiology, 2018; 72(16): 1955–71.
24. MENEGASSI FGM, et al. Miocardiopatia de Takotsubo: Características e Mecanismos Etiológicos, uma revisão narrativa-crítica. Revista Eletrônica Acervo Saúde, 2019; 22: e380.
25. MOADY G, et al. A comparative retrospective study of patients with takotsubo syndrome and acute coronary syndrome. Isr Med Assoc J, 2021; 23(2): 107–10.
26. OTTEN AM, et al. Diagnosis of takotsubo cardiomyopathy is increasing over time in patients presenting as ST-elevation myocardial infarction. Neth Heart J., 2016; 24(9): 520–9.
27. PARODI G, et al. Risk stratification using the cha 2 ds 2 ‐vasc score in takotsubo syndrome: data from the takotsubo italian network. Associação J Am Heart., 2017; 6(9): e006065.
28. PRASAD A, et al. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): A mimic of acute myocardial infarction. American Heart Journal, 2008; 155(3): 408–17.
29. ROSHANZAMIR S, et al. Takotsubo cardiomyopathy a short review. Curr Cardiol., 2013; 9(3): 191–6.
30. SACHDEV E, et al. Women’s Heart Center, Cedars-Sinai Heart Institute, Los Angeles, California, US. Takotsubo cardiomyopathy. European Cardiology Review, 2015; 10(1): 25.
31. SANTORO F, et al. Assessment of the german and italian stress cardiomyopathy score for risk stratification for in-hospital complications in patients with takotsubo syndrome. JAMA Cardiol., 2019; 4(9): 892.
32. SANTOS CRRE, et al. Síndrome de Takotsubo: fisiopatologia, diagnóstico diferencial e tratamento. Revista Eletrônica Acervo Saúde, 2022; 15(2): e9371.
33. SANTOS MTC, et al. Principais características da síndrome de Takotsubo: uma revisão de literatura. Revista Eletrônica Acervo Saúde, 2022; 15(2): e9652.
34. SOUZA MSR, et al. A infecção por coronavírus e a cardiomiopatia de Takotsubo na era da pandemia do SARS-CoV 2. Revista Eletrônica Acervo Científico, 2021; 25: e7368.
35. STIERMAIER T, et al. Prevalence and prognostic impact of diabetes in takotsubo syndrome: insights from the international, multicenter geist registry. Dia Care, 2018; 41(5): 1084–8.
36. SACHDEV E, et al. Women’s Heart Center, Cedars-Sinai Heart Institute, Los Angeles, California, US. Takotsubo cardiomyopathy. European Cardiology Review, 2015; 10(1): 25.
37. TEMPLIN C, et al. Clinical features and outcomes of takotsubo (Stress) cardiomyopathy. N Engl J Med, 2015; 373(10): 929–38.
38. URIBARRI A, et al. Short‐ and long‐term prognosis of patients with takotsubo syndrome based on different triggers: importance of the physical nature. JAHA, 2019; 8(24).
39. VALLABHAJOSYULA S, et al. Tako‐tsubo cardiomyopathy in severe sepsis: nationwide trends, predictors, and outcomes. J Am Heart Assoc., 2018; 7(18).
40. YAYEHD K, et al. Management of takotsubo cardiomyopathy in non-academic hospitals in france: the observational french syndromes of takotsubo (Ofsett) study. Archives of Cardiovascular Diseases, 2016; 109(1): 4–12.
41. YERASI C, et al. Predictors of 90-day readmission and in-hospital mortality in takotsubo cardiomyopathy: an analysis of 28,079 index admissions. Cardiovascular Revascularization Medicine, 2019; 20(11): 973–9.
42. ZALEWSKA-ADAMIEC M, et al. The grace scale in the prognosis of patients with takotsubo syndrome. Journal of Interventional Cardiology, 2020; 2020: 1–7.